Copyright
©The Author(s) 2022.
World J Clin Cases. Oct 26, 2022; 10(30): 11074-11081
Published online Oct 26, 2022. doi: 10.12998/wjcc.v10.i30.11074
Published online Oct 26, 2022. doi: 10.12998/wjcc.v10.i30.11074
Testing items | Results |
Reexamined peripheral blood count | Leukocyte 14.87 × 109/L, hemoglobin 65 g/L; platelet 20 × 109/L and neutrophil 12.46 × 109/L |
Peripheral blood smear | 2% promyelocyte |
Coombs test | Negative |
LDH | 1185 U/L |
ALP | 355 U/L |
Coagulation function | Fibrinogen 1.09 g/L, D-dimer >20000 μg/L |
Serum tumor markers | Carbohydrate antigen 125 236.40 U/mL, ferroprotein > 3000 ng/mL |
- Citation: Shi XB, Deng WX, Jin FX. Bone marrow metastatic neuroendocrine carcinoma with unknown primary site: A case report and review of the literature. World J Clin Cases 2022; 10(30): 11074-11081
- URL: https://www.wjgnet.com/2307-8960/full/v10/i30/11074.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i30.11074